Search

everythinglearnresearchcommunity

for

Search:↓

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Alopecia areata in Taiwan has a high disease burden and needs better research and diagnostic criteria.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Early hair loss links to metabolic issues in young Indian men.

A new method accurately measures steroid hormones in a few hair strands and could help study chronic stress and hair loss.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Severe and early hair loss may indicate a higher risk of heart disease.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Women with early onset androgenetic alopecia have worse lipid profiles.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Timely and aggressive treatment is crucial for improving outcomes in severe complications of adult-onset Still's disease.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Finasteride lowers prostate cancer risk but may increase high-grade tumors and sexual side effects.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Lower lipin 1β in belly fat is linked to insulin resistance in people with polycystic ovary syndrome.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Improving education, training, and access to affordable treatments is crucial for better managing inflammatory skin diseases in Latin America.

Recognizing unusual brain and skin symptoms is crucial for diagnosing lupus early.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

A 45-year-old woman with autoimmune diseases experienced patchy hair loss due to alopecia areata, which has no cure but can be treated, with varying success.

New treatments for severe hair loss often fail, but some patients see hair regrowth with specific therapies, and treatment should be tailored to the individual's situation.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

The drugs finasteride and dutasteride reduce low-grade prostate cancers but may double the risk of high-grade cancers.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.